PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

Interesting article...
http://www.forbes.com/sites/genemarcial/2015/05/25/is-pfizer-on-the-brink-of-a-new-mega-deal/

Prior to joining Alchemia, Mr. Liquard spent seven years with Pfizer in New York where he held various commercial roles of increasing scope and responsibility, including most recently as Senior Director, Portfolio Development Leader, Emerging Markets for the Established Products portfolio. Mr. Liquard also spent three years as a key member of the company's EP US Brands P&L Leadership Team. In this role, he engineered the group's 505(b)(2) investment strategy, culminating in the $700M acquisition of NextWave Pharmaceuticals. He also led the NextWave pre- and post- acquisition integration efforts. In addition, Mr. Liquard worked as a Director within the New Product Planning and Portfolio & Decision Analysis groups at Pfizer. There he was responsible for formulating investment decisions on business development opportunities and internal development programs across multiple therapeutic area -

http://globenewswire.com/news-release/2015/04/14/724305/10128777/en/PharmaCyte-Biotech-Appoints-Former-Pfizer-and-Alchemia-Executive-to-Board-of-Directors.html#sthash.1xP2vnji.dpuf